Sentinel Oncology Partnering

Our business model is to seek out-licensing and collaborative opportunities at the pre-clinical phase.

Interested companies are encouraged to contact us to receive further information and to receive a more detailed R&D information pack.

Sentinel Oncology will also consider in-licensing early stage programmes in the oncology therapeutic area and would encourage organisations and institutions to contact us with any relevant information for review.

For further information on partnering options, please contact us.